ArticleInternational urogynecology journal2026
Outcomes of Total Excision of Retropubic and Transobturator Full Length Mid-Urethral Slings Using Standardised Surgical Techniques in Patients with Mesh Complications: A Retrospective Study Across Two Tertiary Mesh Referral Services.
Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introduction and hypothesisMid-urethral slings (MUS) effectively treat stress urinary incontinence (SUI), although mesh-related complications occur in up to 3% of cases. These include mesh exposure, extrusion, perforation and associated pain; however, additional functional complications associated with sling placement include recurrent SUI, voiding dysfunction, recurrent cystitis symptoms and urge urinary incontinence. While some complications can be managed conservatively, others necessitate surgical excision. Management follows the AUGS-IUGA Joint Statement, although existing literature is limited by heterogenous surgical techniques. We aim to evaluate clinical and patient-reported outcomes following total MUS excision using a standard technique for patients with mesh-related complications.
methodsThis retrospective case series included women undergoing total MUS excision between 2018 and 2024 at two tertiary mesh referral centres. Primary outcomes were symptom resolution and patient satisfaction assessed by Patient Global Impression of Improvement (PGI-I). Secondary outcomes included perioperative complications and postoperative recurrent SUI, including subgroup analysis of concomitant SUI surgery.
resultsA total of 181 patients underwent planned total MUS excision (34.8% retropubic; 65.2% trans-obturator). Complete excision was successful in 99.4%. At median follow-up of 12 months (interquartile range 5-24 months), 91.7% reported resolution of their primary symptoms and 96.1% reported high satisfaction. Significant reductions were observed in pain (92.8% to 19.1%), urge urinary incontinence (65.7% to 44.2%) and recurrent cystitis symptoms (30.4% to 7.2%). Postoperative SUI requiring treatment occurred in 35.2%, lower than preoperative SUI rates (54.1%, p = 0.001). Concomitant SUI surgery reduced postoperative SUI (15.8% vs 37.5%, p < 0.005). No genitourinary fistula or wound breakdown occurred.
conclusionsTotal MUS excision provides high symptom resolution and satisfaction with low complication rates. Post-excision SUI remains common but may be reduced with concomitant surgery in women with proven preoperative urodynamic SUI.
Indexed as
Identifiers
42496745What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.